333 related articles for article (PubMed ID: 6692471)
1. Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation.
Campisi J; Gray HE; Pardee AB; Dean M; Sonenshein GE
Cell; 1984 Feb; 36(2):241-7. PubMed ID: 6692471
[TBL] [Abstract][Full Text] [Related]
2. Growth-dependent synthesis of c-myc-encoded proteins: early stimulation by serum factors in synchronized mouse 3T3 cells.
Persson H; Gray HE; Godeau F
Mol Cell Biol; 1985 Nov; 5(11):2903-12. PubMed ID: 3915769
[TBL] [Abstract][Full Text] [Related]
3. Altered regulation of c-myc expression in adenovirus-transformed cells.
Braithwaite AW; Fry KE; LeJeune S; Naora H
Can J Genet Cytol; 1986 Oct; 28(5):712-24. PubMed ID: 3801968
[TBL] [Abstract][Full Text] [Related]
4. Regulation of c-myc transcription and mRNA abundance by serum growth factors and cell contact.
Dean M; Levine RA; Ran W; Kindy MS; Sonenshein GE; Campisi J
J Biol Chem; 1986 Jul; 261(20):9161-6. PubMed ID: 3722193
[TBL] [Abstract][Full Text] [Related]
5. Effect of cellular density and viral oncogenes on the major histocompatibility complex class I antigen response to gamma-interferon in BALB-c/3T3 cells.
Offermann MK; Faller DV
Cancer Res; 1990 Feb; 50(3):601-5. PubMed ID: 2105158
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of F9 cells is independent of c-myc expression.
Nishikura K; Kim U; Murray JM
Oncogene; 1990 Jul; 5(7):981-8. PubMed ID: 1695728
[TBL] [Abstract][Full Text] [Related]
7. Role of c-myc in the transformation of REF52 cells by viral and cellular oncogenes.
Kohl NE; Ruley HE
Oncogene; 1987; 2(1):41-8. PubMed ID: 2830582
[TBL] [Abstract][Full Text] [Related]
8. Post-transcriptional control of myc and p53 expression during differentiation of the embryonal carcinoma cell line F9.
Dony C; Kessel M; Gruss P
Nature; 1985 Oct 17-23; 317(6038):636-9. PubMed ID: 2414665
[TBL] [Abstract][Full Text] [Related]
9. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
Duddy SK; Earp HS; Russell WE; Smith GJ; Grisham JW
Cell Growth Differ; 1995 Mar; 6(3):251-61. PubMed ID: 7794793
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of an exogenous c-myc gene is insufficient for transformation and tumorigenic conversion of established fibroblasts.
Zerlin M; Julius MA; Cerni C; Marcu KB
Oncogene; 1987 Mar; 1(1):19-27. PubMed ID: 3325875
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle dependent growth factor regulation of gene expression.
Morgan CJ; Pledger WJ
J Cell Physiol; 1989 Dec; 141(3):535-42. PubMed ID: 2512304
[TBL] [Abstract][Full Text] [Related]
12. Cadmium-induced cell transformation and tumorigenesis are associated with transcriptional activation of c-fos, c-jun, and c-myc proto-oncogenes: role of cellular calcium and reactive oxygen species.
Joseph P; Muchnok TK; Klishis ML; Roberts JR; Antonini JM; Whong WZ; Ong T
Toxicol Sci; 2001 Jun; 61(2):295-303. PubMed ID: 11353138
[TBL] [Abstract][Full Text] [Related]
13. Constitutive expression of c-myc oncogene confers hormone independence and enhanced growth-factor responsiveness on cells transformed by human papilloma virus type 16.
Crook T; Almond N; Murray A; Stanley M; Crawford L
Proc Natl Acad Sci U S A; 1989 Aug; 86(15):5713-7. PubMed ID: 2548186
[TBL] [Abstract][Full Text] [Related]
14. Neoplastic transformation of 3T3 mouse embryo cells with c-myc- and c-Ha-ras-1 oncogenes.
Armelin HA; Armelin MC; Kovary K
Braz J Med Biol Res; 1988; 21(6):1155-61. PubMed ID: 3074839
[TBL] [Abstract][Full Text] [Related]
15. Levels of c-myc oncogene mRNA are invariant throughout the cell cycle.
Thompson CB; Challoner PB; Neiman PE; Groudine M
Nature; 1985 Mar 28-Apr 3; 314(6009):363-6. PubMed ID: 3982504
[TBL] [Abstract][Full Text] [Related]
16. Estrogen induction of N-myc and c-myc proto-oncogene expression in the rat uterus.
Murphy LJ; Murphy LC; Friesen HG
Endocrinology; 1987 May; 120(5):1882-8. PubMed ID: 2436892
[TBL] [Abstract][Full Text] [Related]
17. Alternative modes of c-myc regulation in growth factor-stimulated and differentiating cells.
Nepveu A; Levine RA; Campisi J; Greenberg ME; Ziff EB; Marcu KB
Oncogene; 1987; 1(3):243-50. PubMed ID: 2455262
[TBL] [Abstract][Full Text] [Related]
18. Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes.
Blomhoff HK; Smeland EB; Beiske K; Blomhoff R; Ruud E; Bjøro T; Pfeifer-Ohlsson S; Watt R; Funderud S; Godal T
J Cell Physiol; 1987 Jun; 131(3):426-33. PubMed ID: 3036888
[TBL] [Abstract][Full Text] [Related]
19. Unresponsiveness of both non-rearranged and rearranged c-myc to serum stimulation in a mouse plasmacytoma S194.
Kondoh N; Oikawa T; Chiba I; Ogiso Y; Mizuno S; Kuzumaki N
Leuk Res; 1987; 11(12):1149-56. PubMed ID: 2447448
[TBL] [Abstract][Full Text] [Related]
20. Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0/G1.
Freytag SO
Mol Cell Biol; 1988 Apr; 8(4):1614-24. PubMed ID: 2454393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
